4月24日ETF晚报丨多只创新药主题ETF涨超1%；一季度末公募股票ETF持有A股市值27745.72亿元

ETF Industry News Summary Core Insights - The ETF market is experiencing mixed performance, with several innovative drug-themed ETFs showing gains while others in the fintech sector are declining [1][2][5]. Market Performance - Major indices showed varied results, with the Shanghai Composite Index up by 0.03%, while the Shenzhen Component and ChiNext indices fell by 0.58% and 0.68%, respectively [5]. - The average position of newly listed stock ETFs in April is 17.05%, with the highest being 50.02% for the Bosera National Index Large Cap Value ETF [4]. Investment Trends - The Ministry of Industry and Information Technology has issued a plan for the digital transformation of the pharmaceutical industry, emphasizing AI applications and collaboration among leading pharmaceutical companies [2]. - Guotai Junan Securities highlights two key investment themes for 2025: the export of high-quality innovative drugs and the valuation recovery of left-side assets in the pharmaceutical sector [2]. ETF Holdings and Growth - As of the end of Q1 2025, public equity ETFs held a market value of 27,745.72 billion yuan, representing 3.78% of the A-share market's circulating value, a significant increase from 0.37% in June 2015 [3]. - The average fundraising for newly listed ETFs in April was 5.43 million shares, with the largest being the Ping An CSI A500 ETF at 20.27 million shares [4]. Sector Performance - The beauty care, banking, and public utilities sectors performed well today, while the computer, communication, and electronics sectors lagged [7]. - Among different ETF categories, commodity ETFs showed the best average performance with a gain of 0.80%, while cross-border ETFs had the worst performance with a decline of 0.78% [10]. Top Performing ETFs - The top-performing stock ETFs today included the Low Volatility 100 ETF, the CSI 2000 Enhanced ETF, and the Innovative Drug ETF, with gains of 1.81%, 1.57%, and 1.48%, respectively [12][13].